XPD c.934G>A polymorphism of nucleotide excision repair pathway in outcome of head and neck squamous cell carcinoma patients treated with cisplatin chemoradiation.

MLA

Lopes-Aguiar, Leisa, et al. “XPD c.934G>A Polymorphism of Nucleotide Excision Repair Pathway in Outcome of Head and Neck Squamous Cell Carcinoma Patients Treated with Cisplatin Chemoradiation.” Oncotarget, vol. 8, no. 10, Mar. 2017, pp. 16190–201. EBSCOhost, https://doi.org/10.18632/oncotarget.7668.

APA

Lopes-Aguiar, L., Costa, E. F. D., Nogueira, G. A. S., Lima, T. R. P., Visacri, M. B., Pincinato, E. C., Calonga, L., Mariano, F. V., de Almeida Milani Altemani, A. M., Altemani, J. M. C., Coutinho-Camillo, C. M., Ribeiro Alves, M. A. V. F., Moriel, P., Ramos, C. D., Chone, C. T., & Lima, C. S. P. (2017). XPD c.934G>A polymorphism of nucleotide excision repair pathway in outcome of head and neck squamous cell carcinoma patients treated with cisplatin chemoradiation. Oncotarget, 8(10), 16190–16201. https://doi.org/10.18632/oncotarget.7668

Chicago

Lopes-Aguiar, Leisa, Ericka Francislaine Dias Costa, Guilherme Augusto Silva Nogueira, Tathiane Regine Penna Lima, Marília Berlofa Visacri, Eder Carvalho Pincinato, Luciane Calonga, et al. 2017. “XPD c.934G>A Polymorphism of Nucleotide Excision Repair Pathway in Outcome of Head and Neck Squamous Cell Carcinoma Patients Treated with Cisplatin Chemoradiation.” Oncotarget 8 (10): 16190–201. doi:10.18632/oncotarget.7668.